Business Wire

TX-SONAR

1.5.2024 15:01:34 CEST | Business Wire | Press release

Share
Lynne Doherty Joins Sonar as President of Field Operations

Sonar announced today that Lynne Doherty will join the organization as President of Field Operations. In her new role, Lynne will be responsible for driving revenue, and ensuring that Sonar's customers are successful in their pursuit of Clean Code. The leading provider of Clean Code solutions, Sonar accelerates mission-critical software development, reduces technical debt, and improves code quality and code security. Lynne will lead the company’s demand generation, global sales, solutions engineering, customer success, and customer support teams globally.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240501287633/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Lynne Doherty joins Sonar as President of Field Operations to accelerate revenue growth and global expansion. (Photo: Business Wire)

“Lynne has an outstanding track record of leading high-performing go-to-market organizations and driving positive business outcomes. We are excited that she is joining Sonar and believe she’s the ideal leader to help us in our next phase of growth,” said Tariq Shaukat, co-CEO of Sonar. “Having started her career as a Software Developer, she has a strong understanding of the value Sonar creates and a proven track record of working with customers to achieve that value.”

Lynne brings more than 20 years of sales leadership experience to Sonar, most recently as President, of Worldwide Field Operations at Sumo Logic, where she was focused on evolving the GTM organization for operational scale and speed. This included driving customer expansion and growing new logos, shifting the segmentation model, and starting a partner-first motion. Before that, she held various leadership roles at McAfee, where she drove over a billion dollars of revenue annually. In her time at McAfee, she led the team through several business evolutions, supported McAfee’s initial public offering, and multiple acquisitions.

“Sonar is a crucial tool for software developers and engineering teams that is especially necessary for AI-assisted code. With its Clean Code methodology, Sonar addresses a significant gap in the software development lifecycle, enhancing code quality and security hand-in-hand,” said Doherty. “Joining the Sonar team feels personal for me, in a sense, as I’m getting back to my roots as a developer, where I started my career. I’m thrilled to join the Sonar team and look forward to working alongside Tariq, Olivier, and the rest of the organization to deliver Clean Code.”

Before joining McAfee, Lynne held various sales and marketing leadership roles at Cisco, where she oversaw a team of more than 2,000 employees, and drove billions in revenue annually. While at Cisco, she also played a key role in the success of acquisitions of Duo Security, Umbrella, and Cloudlock. Lynne is an independent Director on the boards of CloudBees and the American Red Cross. She holds a B.S. in Mathematics and Computer Science from Temple University.

Over the last 15 years, Sonar has analyzed more than half-a-trillion lines of code across all industries and company sizes, resulting in a deep understanding of how code is written and managed. With that knowledge, Sonar has redefined what it means to write Clean Code in today’s software development life cycle, helping organizations accelerate mission-critical software development, manage proliferating risks, and build fast and reliable applications.

Sonar is currently hiring across a number of departments. You can learn more about joining the Sonar team here.

About Sonar

Sonar is a leading developer of open source solutions to help developers write Clean Code. Sonar’s solutions — SonarQube, SonarCloud, and SonarLint — support over 30 programming languages, frameworks, and infrastructure technologies. Trusted by more than 400,000 organizations globally to clean more than half a trillion lines of code, Sonar is integral to delivering higher quality, better-performing software.

To learn more about Sonar, please visit: https://www.sonarsource.com/products/all/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240501287633/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release

IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye